| Resistance profile and risk factors of drug resistant tuberculosis in the Baltic countries O Ignatyeva, Y Balabanova, V Nikolayevskyy, E Koshkarova, B Radiulyte, ... Tuberculosis 95 (5), 581-588, 2015 | 48 | 2015 |
| Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model J Heyckendorf, S Marwitz, M Reimann, K Avsar, AR DiNardo, G Günther, ... European respiratory journal 58 (3), 2021 | 36 | 2021 |
| Clinical management of multidrug-resistant tuberculosis in 16 European countries G Günther, F van Leth, S Alexandru, N Altet, K Avsar, D Bang, R Barbuta, ... American journal of respiratory and critical care medicine 198 (3), 379-386, 2018 | 36 | 2018 |
| Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in … GH Bothamley, C Lange, D Albrecht, L Anibarro, NA Gomez, ... Respiratory medicine 132, 68-75, 2017 | 7 | 2017 |
| Conventional and molecular diagnosis in a group of patients with drug-resistant tuberculosis R Mindru, V Spînu, C Popa, E Botezatu, R Spătaru Pneumologia (Bucharest, Romania) 63 (3), 168-173, 2014 | 4 | 2014 |
| Pathogen-free diagnosis of tuberculosis J Heyckendorf, M Reimann, S Marwitz, C Lange, K Avsar, AR DiNardo, ... The Lancet Infectious Diseases 21 (8), 1066, 2021 | 3 | 2021 |
| A 22-gene transcriptomic model indicating individual therapy durations in multidrug-resistant tuberculosis J Heyckendorf, S Marwitz, M Reimann, K Avsar, A DiNardo, G Günther, ... medRxiv, 2020.08. 21.20177238, 2020 | 2 | 2020 |
| Drept penal: partea specială I Chipăilă, C Popa, G Ciolan Sitech, 2010 | 2 | 2010 |
| Active Case-Finding: An Effective Solution for Tuberculosis Detection in Vulnerable Groups–The Romanian Experience B Mahler, D Băiceanu, A Stoichiță, D Dendrino, M Mihai, G Ciolan, ... Risk Management and Healthcare Policy, 1115-1125, 2024 | | 2024 |
| A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis N Zielinski, D Baiceanu, A Dragomir, J Heyckendorf, E Ibraim, N Köhler, ... Pathogens and Immunity 9 (2), 25, 2024 | | 2024 |
| Clinical and socio-economic characteristics of a cohort of MDR/XDR TB patients in Bucharest, Romania O Ivanova, D Baiceanu, A Bakuli, M Vogel, C Popa, A Dumitrescu, ... European Journal of Public Health 33 (Supplement_2), ckad160. 998, 2023 | | 2023 |
| Global Fund Special Study: Factors that contribute to favourable MDR-TB treatment C Auer, R Mazitov, A Makhmudov, C Popa, S Khasijev, F Sécula, ... | | 2018 |
| Research letter for the AJRCCM G Gualano, C Magis-Escurra, R Rumetshofer, A Skrahina, V Spinu, ... | | 2017 |
| Particularities of a cohort of preXDR/XDR TB patients treated with group 5 medication, hospitalized in MDR TB Department Institute of Pneumophtisiology Bucharest, Romania G Popescu, C Popa, V Spinu, P Cristian European Respiratory Journal 48 (suppl 60), 2016 | | 2016 |
| The top of the iceberg-Extensively drug resistant tuberculosis (XDR-TB) in 2010 RE Nedelcu, G Popescu, V Spinu, C Popa European Respiratory Journal 46 (suppl 59), 2015 | | 2015 |
| Artificial therapeutic pneumothorax induced by video assisted thoracoscopic surgery–Surgical treatment option in the modern management of pulmonary tuberculosis–Case presentation O Danaila, C Paleru, C Bolca, A Istrate, C Popa, G Cadar, I Cordos European Respiratory Journal 38 (Suppl 55), 2011 | | 2011 |
| Characteristics of the course of the last epidemic of epidemic cerebrospinal meningitis (ECSM) in the city of Bucharest V Ionescu, C Busuioc, P Bordeianu, A Tisu, E Guguianu, C Popa Revista de Igiena, Bacteriologie, Virusologie, Parazitologie, Epidemiologie …, 1975 | | 1975 |
| Shifting to the ambulatory patient-centered tuberculosis care model in Romania–preliminary results of the pilot project conducted in Marius Nasta Institute of Pneumology … I Munteanu, C Popa, C Popa, C Cazacu, A Pleșită, C Teoibas, N Cioran, ... Pneumologia 69 (4), 234-240, 0 | | |
